The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2017
Filed:
Apr. 17, 2013
Applicant:
University College Dublin, National University of Ireland, Dublin, Dublin, IE;
Inventors:
B. Therese Kinsella, Blackrock, IE;
Helen Reid, Dublin, IE;
Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); C07D 213/71 (2006.01); C07D 231/12 (2006.01); C07D 261/08 (2006.01); C07D 307/42 (2006.01); C07D 213/34 (2006.01); C07D 277/34 (2006.01); C07D 295/192 (2006.01); C07D 263/48 (2006.01); C07D 305/08 (2006.01); C07D 205/04 (2006.01); C07D 213/85 (2006.01);
U.S. Cl.
CPC ...
C07D 213/71 (2013.01); A61K 31/18 (2013.01); C07D 205/04 (2013.01); C07D 213/34 (2013.01); C07D 213/85 (2013.01); C07D 231/12 (2013.01); C07D 261/08 (2013.01); C07D 263/48 (2013.01); C07D 277/34 (2013.01); C07D 295/192 (2013.01); C07D 305/08 (2013.01); C07D 307/42 (2013.01);
Abstract
The invention generally relates to methods and compounds for treating proliferative disorders, viral infections, or both. In some embodiments, the invention provides an anticancer or antiviral compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating a proliferative disorder or a viral infection including administering an anticancer or antiviral compound that binds to a thromboxane receptor, has preferential binding for either TPalpha (TPα) or TPbeta (TPβ) receptor subtype.